GoodRx (Nasdaq: GDRX) announced it is working with ARS Pharmaceuticals to offer the lowest discounted cash price for neffy in ...

In a report released today, Jailendra Singh from Truist Financial assigned a Hold rating to GoodRx Holdings (GDRX – Research Report). The ...

GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., today announced it is working with ARS ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 78.58% ...

Goodrx Holdings Inc (GDRX) stock saw a decline, ending the day at $7.59 which represents a decrease of $-0.09 or -1.17% from the prior close of $7.68. The stock opened at $7.75 and touched a low of $7 ...

Navigating the complex world of prescription drug pricing can feel overwhelming, particularly with the ever-increasing costs ...

GoodRx Holdings, Inc. (GDRX) reported $200.61 million in revenue for the quarter ended June 2024, representing a year-over-year increase of 5.8%. EPS of $0.08 for the same period compares to $0.07 ...

SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," “GoodRx,” or the “Company”), the leading prescription savings ...

George Hill has given his Hold rating due to a combination of factors that reflect GoodRx Holdings’ mixed performance and uncertain future prospects. In the second quarter, the company reported ...

GoodRx Holdings Inc provides a platform that helps consumers in the United States save on prescription drugs. By offering a price comparison tool, GoodRx enables users to find the best prices for ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...